文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

可溶性程序性死亡受体-1对急诊脓毒症患者风险分层与预后评估的价值

The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.
PubMed 文献 · Am J Emerg Med · 2017-07-04
一句话结论急诊脓毒症患者血清sPD-1随病情严重程度升高,是28天死亡的独立危险因素,与PCT、MEDS评分联用可提高预后评估效能(AUC 0.843)。

该前瞻性队列研究纳入60名健康志愿者和595例急诊患者,按入急诊时病情分为全身炎症反应综合征组(130例)、脓毒症组(276例)、严重脓毒症组(121例)和脓毒性休克组(68例),脓毒症患者再按28天结局分为存活组(349例)和死亡组(116例)。随脓毒症严重程度增加,sPD-1水平逐渐升高;死亡组sPD-1、PCT、CRP和MEDS评分均高于存活组。Logistic回归显示sPD-1、PCT和MEDS评分是28天死亡的独立危险因素。sPD-1、PCT、MEDS评分预测28天死亡的AUC分别为0.725、0.693、0.767,三者联合后AUC提高至0.843。

要点

  • 急诊脓毒症患者血清sPD-1水平随病情严重程度(SIRS→脓毒症→严重脓毒症→脓毒性休克)逐渐升高。
  • 28天死亡组sPD-1、PCT、CRP和MEDS评分均高于存活组。
  • sPD-1、PCT和MEDS评分均为脓毒症患者28天死亡的独立危险因素。
  • sPD-1预测28天死亡的AUC为0.725,PCT为0.693,MEDS评分为0.767。
  • sPD-1联合PCT和MEDS评分预测28天死亡的AUC提高至0.843。

适用人群与场景

  • 急诊科就诊的脓毒症患者,按入急诊时病情严重程度分为全身炎症反应综合征组(130例)、脓毒症组(276例)、严重脓毒症组(121例)和脓毒性休克组(68例)。
  • 另纳入60名健康志愿者作为对照。

研究设计与关键结果

  • 前瞻性队列研究,纳入60名健康志愿者和595例急诊患者,脓毒症患者按28天结局分为存活组(349例)和死亡组(116例)。
  • 随脓毒症严重程度增加,sPD-1水平逐渐升高。
  • 死亡组sPD-1、PCT、CRP和MEDS评分均高于存活组。
  • Logistic回归显示sPD-1、PCT和MEDS评分是脓毒症患者28天死亡的独立危险因素。
  • sPD-1、PCT和MEDS评分预测28天死亡的AUC分别为0.725、0.693、0.767。
  • sPD-1联合PCT和MEDS评分预测28天死亡的AUC提高至0.843。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血清sPD-1与脓毒症严重程度正相关,对患者风险分层和28天死亡预测有价值。
  • 作者认为sPD-1联合PCT和MEDS评分可改善预后评估。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the efficacy of soluble programmed death-1 (sPD-1) for risk stratification and prediction of 28-day mortality in patients with sepsis, we compared serum sPD-1 with procalcitonin (PCT), C-reactive protein (CRP), and the Mortality in Emergency Department Sepsis (MEDS) score.

METHODS: A total of 60 healthy volunteers and 595 emergency department (ED) patients were recruited for this prospective cohort study. According to the severity of their condition on ED arrival, the patients were allocated to the systemic inflammatory response syndrome group (130 cases), sepsis group (276 cases), severe sepsis group (121 cases), and septic shock group (68 cases). In addition, all patients with sepsis were also divided into the survivor group (349 cases) and nonsurvivor group (116 cases) according to the 28-day outcomes.

RESULTS: When the severity of sepsis increased, the levels of sPD-1 gradually increased. The levels of sPD-1, PCT, CRP and the MEDS score were also higher in the nonsurvivor group compared to the survivor group. Logistic regression suggested that sPD-1, PCT, and the MEDS score were independent risk factors for 28-day mortality of patients with sepsis. Area under the curve (AUC) of sPD-1, PCT and the MEDS score for 28-day mortality was 0.725, 0.693, and 0.767, respectively, and the AUC was improved when all 3 factors were combined (0.843).

CONCLUSION: Serum sPD-1 is positively correlated with the severity of sepsis, and it is valuable for risk stratification of patients and prediction of 28-day mortality. Combining sPD-1 with PCT and the MEDS score improves the prognostic evaluation.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Zhao Y, Jia Y, Li C, et al. The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department. Am J Emerg Med. 2017. PMID: 28716595. doi:10.1016/j.ajem.2017.07.002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。